Clinical Trial Update: Patient-derived Organoids of Lung Cancer to Test Drug Response

View source ↗

Summary

A trial uses patient-derived organoids from lung cancer patients to test drug response. It is currently recruiting at University Hospital, Geneva.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University Hospital, Geneva | Conditions: Lung Cancer, Organoid | Status: RECRUITING